Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 17alpha-ethynylestradiol | increases expression | ISO | Gtf2f1 (Mus musculus) | 6480464 | Ethinyl Estradiol results in increased expression of GTF2F1 mRNA | CTD | PMID:17942748 | 17alpha-ethynylestradiol | decreases expression | EXP | | 6480464 | Ethinyl Estradiol results in decreased expression of GTF2F1 mRNA | CTD | PMID:29097150 | 17alpha-ethynylestradiol | multiple interactions | ISO | Gtf2f1 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of GTF2F1 mRNA | CTD | PMID:17942748 | 2,2',4,4'-Tetrabromodiphenyl ether | affects expression | ISO | Gtf2f1 (Mus musculus) | 6480464 | 2 more ... | CTD | PMID:30294300 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Gtf2f1 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of GTF2F1 mRNA | CTD | PMID:17942748 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Gtf2f1 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of GTF2F1 mRNA | CTD | PMID:21570461 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of GTF2F1 mRNA | CTD | PMID:22298810 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of GTF2F1 mRNA | CTD | PMID:16960034 and PMID:34747641 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Gtf2f1 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of GTF2F1 mRNA | CTD | PMID:16960034 | 2,4-dinitrotoluene | affects expression | EXP | | 6480464 | 2 and 4-dinitrotoluene affects the expression of GTF2F1 mRNA | CTD | PMID:21346803 | 2,6-dinitrotoluene | affects expression | EXP | | 6480464 | 2 and 6-dinitrotoluene affects the expression of GTF2F1 mRNA | CTD | PMID:21346803 | 2-methylcholine | affects expression | ISO | GTF2F1 (Homo sapiens) | 6480464 | beta-methylcholine affects the expression of GTF2F1 mRNA | CTD | PMID:21179406 | 4,4'-sulfonyldiphenol | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of GTF2F1 mRNA | CTD | PMID:36041667 | acetamide | increases expression | EXP | | 6480464 | acetamide results in increased expression of GTF2F1 mRNA | CTD | PMID:31881176 | acrolein | multiple interactions | ISO | GTF2F1 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of GTF2F1 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of GTF2F1 mRNA | CTD | PMID:32699268 | alpha-pinene | multiple interactions | ISO | GTF2F1 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of GTF2F1 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of GTF2F1 mRNA | CTD | PMID:32699268 | antirheumatic drug | decreases expression | ISO | GTF2F1 (Homo sapiens) | 6480464 | Antirheumatic Agents results in decreased expression of GTF2F1 mRNA | CTD | PMID:24449571 | aristolochic acid A | increases expression | ISO | GTF2F1 (Homo sapiens) | 6480464 | aristolochic acid I results in increased expression of GTF2F1 mRNA | CTD | PMID:33212167 | benzatropine | multiple interactions | ISO | GTF2F1 (Homo sapiens) | 6480464 | [Cuprizone co-treated with Benztropine] results in decreased expression of GTF2F1 protein | CTD | PMID:34122009 | benzo[a]pyrene | increases expression | ISO | Gtf2f1 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of GTF2F1 mRNA | CTD | PMID:22228805 | bis(2-chloroethyl) sulfide | increases phosphorylation | ISO | GTF2F1 (Homo sapiens) | 6480464 | Mustard Gas results in increased phosphorylation of GTF2F1 protein | CTD | PMID:19845377 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of GTF2F1 mRNA | CTD | PMID:25181051 more ... | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of GTF2F1 mRNA | CTD | PMID:36041667 | bisphenol A | decreases expression | ISO | Gtf2f1 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of GTF2F1 mRNA | CTD | PMID:33221593 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of GTF2F1 mRNA | CTD | PMID:29097150 and PMID:33296240 | bisphenol F | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of GTF2F1 mRNA | CTD | PMID:36041667 | Brodifacoum | increases expression | EXP | | 6480464 | bromfenacoum results in increased expression of GTF2F1 protein | CTD | PMID:28903499 | butan-1-ol | multiple interactions | ISO | GTF2F1 (Homo sapiens) | 6480464 | [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of GTF2F1 mRNA | CTD | PMID:29432896 | cadmium dichloride | increases methylation | EXP | | 6480464 | Cadmium Chloride results in increased methylation of GTF2F1 promoter | CTD | PMID:22457795 | cannabidiol | multiple interactions | ISO | GTF2F1 (Homo sapiens) | 6480464 | [Cuprizone co-treated with Cannabidiol] results in decreased expression of GTF2F1 protein | CTD | PMID:34122009 | carbon nanotube | increases expression | ISO | Gtf2f1 (Mus musculus) | 6480464 | Nanotubes and Carbon analog results in increased expression of GTF2F1 mRNA | CTD | PMID:25554681 | carmustine | decreases expression | ISO | GTF2F1 (Homo sapiens) | 6480464 | Carmustine results in decreased expression of GTF2F1 mRNA | CTD | PMID:15980968 | carnosic acid | decreases expression | ISO | Gtf2f1 (Mus musculus) | 6480464 | salvin results in decreased expression of GTF2F1 protein | CTD | PMID:35926579 | chlorpyrifos | decreases expression | ISO | Gtf2f1 (Mus musculus) | 6480464 | Chlorpyrifos results in decreased expression of GTF2F1 mRNA | CTD | PMID:37019170 | cobalt dichloride | increases expression | ISO | GTF2F1 (Homo sapiens) | 6480464 | cobaltous chloride results in increased expression of GTF2F1 mRNA | CTD | PMID:19320972 and PMID:19376846 | coumarin | increases phosphorylation | ISO | GTF2F1 (Homo sapiens) | 6480464 | coumarin results in increased phosphorylation of GTF2F1 protein | CTD | PMID:35688186 | Cuprizon | multiple interactions | ISO | GTF2F1 (Homo sapiens) | 6480464 | [Cuprizone co-treated with Benztropine] results in decreased expression of GTF2F1 protein and [Cuprizone co-treated with Cannabidiol] results in decreased expression of GTF2F1 protein | CTD | PMID:34122009 | cyclosporin A | increases expression | ISO | GTF2F1 (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of GTF2F1 mRNA | CTD | PMID:25562108 | dextran sulfate | increases expression | ISO | Gtf2f1 (Mus musculus) | 6480464 | Dextran Sulfate results in increased expression of GTF2F1 mRNA | CTD | PMID:35093514 | diazinon | increases methylation | ISO | GTF2F1 (Homo sapiens) | 6480464 | Diazinon results in increased methylation of GTF2F1 gene | CTD | PMID:22964155 | dibutyl phthalate | increases expression | EXP | | 6480464 | Dibutyl Phthalate results in increased expression of GTF2F1 mRNA | CTD | PMID:21266533 | dibutyl phthalate | decreases expression | ISO | Gtf2f1 (Mus musculus) | 6480464 | Dibutyl Phthalate results in decreased expression of GTF2F1 mRNA | CTD | PMID:17361019 | elemental selenium | increases expression | ISO | GTF2F1 (Homo sapiens) | 6480464 | Selenium results in increased expression of GTF2F1 mRNA | CTD | PMID:19244175 | ethanol | affects expression | ISO | Gtf2f1 (Mus musculus) | 6480464 | Ethanol affects the expression of GTF2F1 mRNA | CTD | PMID:30319688 | flutamide | increases expression | EXP | | 6480464 | Flutamide results in increased expression of GTF2F1 mRNA | CTD | PMID:24136188 | FR900359 | affects phosphorylation | ISO | GTF2F1 (Homo sapiens) | 6480464 | FR900359 affects the phosphorylation of GTF2F1 protein | CTD | PMID:37730182 | genistein | decreases expression | ISO | GTF2F1 (Homo sapiens) | 6480464 | Genistein results in decreased expression of GTF2F1 mRNA | CTD | PMID:16705744 | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of GTF2F1 mRNA | CTD | PMID:33387578 | glafenine | increases expression | EXP | | 6480464 | Glafenine results in increased expression of GTF2F1 mRNA | CTD | PMID:24136188 | isobutanol | multiple interactions | ISO | GTF2F1 (Homo sapiens) | 6480464 | [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of GTF2F1 mRNA | CTD | PMID:29432896 | ivermectin | decreases expression | ISO | GTF2F1 (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of GTF2F1 protein | CTD | PMID:32959892 | lead diacetate | affects expression | EXP | | 6480464 | lead acetate affects the expression of GTF2F1 protein | CTD | PMID:36539177 | lead(0) | decreases expression | ISO | GTF2F1 (Homo sapiens) | 6480464 | Lead results in decreased expression of GTF2F1 mRNA | CTD | PMID:19921347 | methidathion | decreases expression | ISO | Gtf2f1 (Mus musculus) | 6480464 | methidathion results in decreased expression of GTF2F1 mRNA | CTD | PMID:34813904 | methyl methanesulfonate | increases expression | ISO | GTF2F1 (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in increased expression of GTF2F1 mRNA | CTD | PMID:23649840 | miconazole | increases expression | ISO | Gtf2f1 (Mus musculus) | 6480464 | Miconazole results in increased expression of GTF2F1 mRNA | CTD | PMID:27462272 | ozone | multiple interactions | ISO | GTF2F1 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of GTF2F1 mRNA more ... | CTD | PMID:32699268 and PMID:35430440 | ozone | decreases expression | ISO | GTF2F1 (Homo sapiens) | 6480464 | Ozone results in decreased expression of GTF2F1 mRNA | CTD | PMID:23033980 | paracetamol | affects expression | ISO | Gtf2f1 (Mus musculus) | 6480464 | Acetaminophen affects the expression of GTF2F1 mRNA | CTD | PMID:17562736 | pirinixic acid | decreases expression | ISO | Gtf2f1 (Mus musculus) | 6480464 | pirinixic acid results in decreased expression of GTF2F1 mRNA | CTD | PMID:17426115 | pirinixic acid | increases expression | ISO | Gtf2f1 (Mus musculus) | 6480464 | pirinixic acid results in increased expression of GTF2F1 mRNA | CTD | PMID:18301758 | selenium atom | increases expression | ISO | GTF2F1 (Homo sapiens) | 6480464 | Selenium results in increased expression of GTF2F1 mRNA | CTD | PMID:19244175 | sodium dichromate | increases expression | EXP | | 6480464 | sodium bichromate results in increased expression of GTF2F1 mRNA | CTD | PMID:25993096 | tert-butyl hydroperoxide | decreases expression | ISO | GTF2F1 (Homo sapiens) | 6480464 | tert-Butylhydroperoxide results in decreased expression of GTF2F1 mRNA | CTD | PMID:15336504 | tetrachloroethene | decreases expression | ISO | Gtf2f1 (Mus musculus) | 6480464 | Tetrachloroethylene results in decreased expression of GTF2F1 mRNA | CTD | PMID:28973375 | tetrachloromethane | increases expression | ISO | Gtf2f1 (Mus musculus) | 6480464 | Carbon Tetrachloride results in increased expression of GTF2F1 mRNA | CTD | PMID:27339419 and PMID:31919559 | thimerosal | decreases expression | ISO | GTF2F1 (Homo sapiens) | 6480464 | Thimerosal results in decreased expression of GTF2F1 mRNA | CTD | PMID:27188386 | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of GTF2F1 mRNA | CTD | PMID:23411599 and PMID:34492290 | Triptolide | increases expression | ISO | Gtf2f1 (Mus musculus) | 6480464 | triptolide results in increased expression of GTF2F1 mRNA | CTD | PMID:32835833 | tungsten | decreases expression | ISO | Gtf2f1 (Mus musculus) | 6480464 | Tungsten results in decreased expression of GTF2F1 mRNA | CTD | PMID:30912803 | valproic acid | affects expression | ISO | Gtf2f1 (Mus musculus) | 6480464 | Valproic Acid affects the expression of GTF2F1 mRNA | CTD | PMID:17292431 | valproic acid | increases expression | ISO | GTF2F1 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of GTF2F1 mRNA | CTD | PMID:23179753 | valproic acid | increases methylation | ISO | GTF2F1 (Homo sapiens) | 6480464 | Valproic Acid results in increased methylation of GTF2F1 gene | CTD | PMID:29154799 | vitamin E | decreases expression | ISO | GTF2F1 (Homo sapiens) | 6480464 | Vitamin E results in decreased expression of GTF2F1 mRNA | CTD | PMID:19244175 | |